| 1Z8C | A:; B: | CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 |
| 2B60 | A:; B: | STRUCTURE OF HIV-1 PROTEASE MUTANT BOUND TO RITONAVIR |
| 2B7Z | A:; B: | STRUCTURE OF HIV-1 PROTEASE MUTANT BOUND TO INDINAVIR |
| 2F3K | A:; B: | SUBSTRATE ENVELOPE AND DRUG RESISTANCE: CRYSTAL STRUCTURE OF R01 IN COMPLEX WITH WILD-TYPE HIV-1 PROTEASE |
| 2FDD | A:; B: | CRYSTAL STRUCTURE OF HIV PROTEASE D545701 BOUND WITH GW0385 |
| 2FLE | A:; B: | STRUCTURAL ANALYSIS OF ASYMMETRIC INHIBITOR BOUND TO THE HIV-1 PROTEASE V82A MUTANT |
| 2G69 | A: | STRUCTURE OF UNLIGANDED HIV-1 PROTEASE F53L MUTANT |
| 2HB2 | A: | STRUCTURE OF HIV PROTEASE 6X MUTANT IN APO FORM |
| 2HC0 | A:; B: | STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2. |
| 2J9J | A:; B: | ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR JG-365 |
| 2JE4 | A:; B: | ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365 |
| 2P3D | A:; B: | CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE F HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR |
| 2QD6 | A:; B: | HIV-1 PROTEASE MUTANT I50V WITH POTENT ANTIVIRAL INHIBITOR GRL-98065 |
| 3ZPS | A:; B: | DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS |
| 3ZPT | A:; B: | DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS |
| 3ZPU | A:; B: | DESIGN AND SYNTHESIS OF P1-P3 MACROCYCLIC TERTIARY ALCOHOL COMPRISING HIV-1 PROTEASE INHIBITORS |
| 4NJS | A:; C: | CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL008 |
)
)